Endo International Plc (ENDP):企業の財務・戦略的SWOT分析

◆英語タイトル:Endo International Plc (ENDP) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C15905
◆発行会社(調査会社):GlobalData
◆発行日:2019年4月
◆ページ数:58
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アイルランド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥40,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Endo International Plc (ENDP) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Endo International Plc (Endo) is a specialty healthcare company that develops, manufactures and commercializes various branded pharmaceutical products, generic pharmaceuticals and other products through its operating companies. It sells generic products principally in the US in various categories including urology, pain management, central nervous system (CNS) disorders, immunosuppression, cancer, cardiovascular diseases and women’s health among others. The company offers branded pharmaceuticals for conditions related to urology, orthopedics, endocrinology and pain management. Endo also provides over-the-counter (OTC) products, which include dermatological products and anti-infectives. The company sells its products through independent wholesale distributors, to retailers, government agencies, doctors, clinics, independent retail and specialty pharmacies and independent specialty distributors. Endo is headquartered in Dublin, Ireland.

Endo International Plc Key Recent Developments

Mar 23,2019 Sojournix Poster Presentation At ENDO 2019 Features Positive Data From SJX-653 Proof-of-Mechanism Clinical Study
Mar 04,2019 Right on Brands (RTON) Exclusive Distribution Deal With South Florida Budweiser Distributor For ENDO Brands Products Kicks off sales week
Mar 01,2019 Endo Will Showcase Late-Breaking Phase 3 CCH Data at the 2019 American Academy of Dermatology Annual Meeting
Feb 28,2019 Endo reports fourth-quarter and full year 2018 financial results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Endo International Plc – Key Facts
Endo International Plc – Key Employees
Endo International Plc – Key Employee Biographies
Endo International Plc – Major Products and Services
Endo International Plc – History
Endo International Plc – Company Statement
Endo International Plc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Endo International Plc – Business Description
Business Segment: International Pharmaceuticals
Overview
Performance
Business Segment: U.S. Branded – Specialty & Established Pharmaceuticals
Overview
Performance
Business Segment: U.S. Branded – Sterile Injectables
Overview
Performance
Business Segment: U.S. Generic Pharmaceuticals
Overview
Performance
R&D Overview
Endo International Plc – Corporate Strategy
Endo International Plc – SWOT Analysis
SWOT Analysis – Overview
Endo International Plc – Strengths
Endo International Plc – Weaknesses
Endo International Plc – Opportunities
Endo International Plc – Threats
Endo International Plc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Endo International Plc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Endo International Plc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Endo International Plc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 23, 2019: Sojournix Poster Presentation At ENDO 2019 Features Positive Data From SJX-653 Proof-of-Mechanism Clinical Study
Mar 04, 2019: Right on Brands (RTON) Exclusive Distribution Deal With South Florida Budweiser Distributor For ENDO Brands Products Kicks off sales week
Mar 01, 2019: Endo Will Showcase Late-Breaking Phase 3 CCH Data at the 2019 American Academy of Dermatology Annual Meeting
Feb 28, 2019: Endo reports fourth-quarter and full year 2018 financial results
Jan 15, 2019: BGS-649 Phase 2b data to be Presented at ENDO 2019
Nov 28, 2018: Amsel Medical Corporation Announces Clearance of a 510(k) Pre-Marketing Notification by the US Food and Drug Administration for the Amsel Endo Occluder Device
Nov 09, 2018: Endo Pharmaceuticals Issues Voluntary Recall of Robaxin Tablets Bottle Packs due to Labeling Error
Nov 08, 2018: Endo reports third-quarter 2018 financial results
Oct 11, 2018: Endo presents data on the perception and measurement of cellulite severity at the American Society for Dermatologic Surgery (ASDS) Annual Meeting
Sep 28, 2018: Endo Pharmaceuticals Issues Voluntary Nationwide Recall for Two Lots of Robaxin® 750mg Tablets 100 Count Bottle Packs Due to Incorrect Daily Dosing Information on Label
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Endo International Plc, Key Facts
Endo International Plc, Key Employees
Endo International Plc, Key Employee Biographies
Endo International Plc, Major Products and Services
Endo International Plc, History
Endo International Plc, Other Locations
Endo International Plc, Subsidiaries
Endo International Plc, Key Competitors
Endo International Plc, Ratios based on current share price
Endo International Plc, Annual Ratios
Endo International Plc, Annual Ratios (Cont...1)
Endo International Plc, Annual Ratios (Cont...2)
Endo International Plc, Interim Ratios
Endo International Plc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Endo International Plc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Endo International Plc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Endo International Plc, Performance Chart (2014 - 2018)
Endo International Plc, Ratio Charts
Endo International Plc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Endo International Plc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

★海外企業調査レポート[Endo International Plc (ENDP):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Acella Pharmaceuticals, LLC(製薬・医療分野):企業M&A動向
    Summary Acella Pharmaceuticals, LLC (Acella Pharmaceuticals) is a pharmaceutical company. The company develops and commercializes pharmaceutical products in therapeutic areas such as women’s health and dermatology. The company offers products in therapeutic categories including dermatology, women’s …
  • Action Manufacturing Company(航空宇宙・防衛):企業概要及びSWOT/財務分析
    Summary Strategic Defence Intelligence's "Action Manufacturing Company: Aerospace and Defense - Company Profile and SWOT Analysis" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, SWOT analys …
  • Marathon Petroleum Corporation:企業の戦略・SWOT・財務分析
    SummaryMarathon Petroleum Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the compa …
  • Bharat Heavy Electricals Limited (BHEL):企業のM&A・提携・投資分析
    Bharat Heavy Electricals Limited (BHEL) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Bharat Heavy Electricals Limited (BHEL) Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed re …
  • Africa-Israel Investments, Ltd.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Africa-Israel Investments, Ltd. …
  • Key Energy Services, Inc. (KEG):企業概要、財務及び戦略的SWOT分析
    Summary Key Energy Services, Inc. (Key Energy) is an oil and gas service provider. The company provides a wide range of onshore energy production services to major oil and gas companies. Key Energy’s service portfolio includes services such as rig services, rental services, coiled tubing, fluid mana …
  • Huafu Top Dyed Melange Yarn Co.,Ltd.の企業概要及び財務/SWOT分析
    Huafu Top Dyed Melange Yarn Co.,Ltd. Fundamental Company Report provides a complete overview of the company’s affairs. The report includes financial and SWOT information, industry analysis, opinions, estimates, Huafu Top Dyed Melange Yarn Co.,Ltd. annual and quarterly forecasts made by stock market …
  • BMG Resources Limited (BMG):企業概要、財務及び戦略的SWOT分析
    Summary BMG Resources Limited (BMG) formerly Brazilian Metals Group Limited, is an exploration company. The company is into exploring a highly prospective portfolio of exploration tenements in the Republic of Cyprus. It offers products such as Nickel, Copper, Gold and Cobalt. BMG operates with coppe …
  • Ildong Pharmaceutical Co Ltd (000230):企業の財務・戦略的SWOT分析
    Summary Ildong Pharmaceutical Co Ltd (IPC) is a manufacturer of pharmaceutical products. The company offers finished drugs, health foods and foods, raw material drugs, cosmetics and medical devices and others. Its raw material drugs comprise synthesis, probiotics, vitamins and biometabolites. IPC al …
  • ARUP Laboratories:企業の戦略的SWOT分析
    ARUP Laboratories - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • First National Bank (FNB):企業概要・SWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "First National Bank (FNB)" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Timetric strictly …
  • Myelin Repair Foundation:企業のM&A・提携動向(医療分野)
    Summary Myelin Repair Foundation (MRF) is a medical research organization that discovers and develops myelin repair therapeutics for multiple sclerosis. The organization publishes various peer-reviewed scientific articles, identifies different myelin repair treatment targets and discovers multiple r …
  • Smith Micro Software, Inc. (SMSI):企業財務及び戦略的SWOT分析
    Summary Smith Micro Software, Inc. (Smith Micro) is a software development company that develops productivity and graphic software products for professional artists and general consumers. The company’s products include NetWise, QuickLink, consumer and CommSuite products. Its NetWise products compris …
  • Aleris International, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Aleris International, Inc. Merg …
  • Daimler AG (DAI)-エネルギー分野:企業M&A・提携分析
    Summary Daimler AG (Daimler) is an automobile company that undertakes the manufacture, distribution and sales of premium passenger cars, commercial vehicles and related spare part and accessories. The company also provides services such as financing, leasing, fleet management, insurance, financial i …
  • Kracie Holdings, Ltd.:戦略・SWOT・企業財務分析
    Kracie Holdings, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Kracie Holdings, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Paranta Biosciences Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Paranta Biosciences Ltd (Paranta Biosciences) is a clinical stage biopharmaceutical company which develops follistatin-based bio-therapeutic for the treatment of inflammatory and fibrotic diseases. The company’s lead product candidate PB01, a recombinant human follistatin-288 is under phase …
  • Hanergy Holding Group Ltd.:企業のM&A・提携動向(エネルギー分野)
    Summary Hanergy Holding Group Limited (Hanergy) is a clean energy company that provides solar energy solutions. The company’s businesses consist of thin-film solar power generation, hydropower, wind power, energy conservation and emission reduction. Its thin-film solar technology finds application i …
  • Biotica Technology Ltd(製薬・医療分野):企業M&A動向
    Summary Biotica Technology Ltd (Biotica) is a biotechnology company. The company manufactures and distributes drugs for cancer and inflammatory diseases. Its products include mTOR inhibitors, Hsp90 inhibitors, apoptosis inducers, and angiogenesis inhibitors. Biotica products are based on its patente …
  • NeoMend, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' NeoMend, Inc. Mergers and Acqui …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆